Meeting
2020 Gastrointestinal Cancers Symposium
ARID1A mutation to define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer.
Authors
Amir Mehrvarz Sarshekeh
University of Texas MD Anderson Cancer Center, Houston, TX
Amir Mehrvarz Sarshekeh , Jason Roszik , Ganiraju C. Manyam , Shailesh M. Advani , Jason Willis , John Paul Y.C. Shen , Jeffrey Morris , Jennifer S. Davis , Jaffer A. Ajani , Dipen M. Maru , Michael J. Overman , Scott Kopetz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 215)
Abstract #
215
Poster Bd #
K15
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita
Poster
2022 ASCO Annual Meeting
Comprehensive characterization of PTPRT expression in colorectal cancer (CRC).
First Author: Francesca Battaglin
Poster
2022 ASCO Annual Meeting
Characterization of NY-ESO-1 gene expression in gastric cancer (GC).
First Author: Annika Lenz
Poster
2019 Gastrointestinal Cancers Symposium
Expression patterns of PD-L1 and other immune checkpoint molecules in gastric cancer.
First Author: Kenichi Nakamura